Gene · 4176
Papers3,001
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,001
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ubiquitin-assisted phase separation of dishevelled-2 promotes Wnt signalling. | J Cell Sci | 2022 | 36398662 | PubTator, text mining | PubMed |
| Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylation. | Nat Commun | 2022 | 36376293 | PubTator, text mining | PubMed |
| Loss of transcription factor EB dysregulates the G1/S transition and DNA replication in mammary epithelial cells. | J Biol Chem | 2022 | 36372230 | PubTator, text mining | PubMed |
| Correction to: MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma. | Cell Death Dis | 2022 | 36357373 | PubTator, text mining | PubMed |
| PRMT3 drives glioblastoma progression by enhancing HIF1A and glycolytic metabolism. | Cell Death Dis | 2022 | 36351894 | PubTator, text mining | PubMed |
| DNA replication initiation shapes the mutational landscape and expression of the human genome. | Sci Adv | 2022 | 36351018 | PubTator, text mining | PubMed |
| In silico investigation of the role of vitamins in cancer therapy through inhibition of MCM7 oncoprotein. | RSC Adv | 2022 | 36349041 | PubTator, text mining | PubMed |
| Low-molecular-weight cyclin E deregulates DNA replication and damage repair to promote genomic instability in breast cancer. | Oncogene | 2022 | 36344674 | PubTator, text mining | PubMed |
| UBE2T promotes breast cancer tumor growth by suppressing DNA replication stress. | NAR Cancer | 2022 | 36338541 | PubTator, text mining | PubMed |
| Integrated Molecular Analysis Reveals 2 Distinct Subtypes of Pure Seminoma of the Testis. | Cancer Inform | 2022 | 36330202 | PubTator, text mining | PubMed |
| Cooperative assembly of p97 complexes involved in replication termination. | Nat Commun | 2022 | 36329031 | PubTator, text mining | PubMed |
| Applying differential network analysis to longitudinal gene expression in response to perturbations. | Front Genet | 2022 | 36324501 | PubTator, text mining | PubMed |
| Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer. | Biol Direct | 2022 | 36319976 | PubTator, text mining | PubMed |
| Conformationally Defined Rexinoids for the Prevention of Inflammation and Nonmelanoma Skin Cancers. | J Med Chem | 2022 | 36318154 | PubTator, text mining | PubMed |
| MCM2 in human cancer: functions, mechanisms, and clinical significance. | Mol Med | 2022 | 36303105 | PubTator, text mining | PubMed |
Identification of EGFR-Related LINC00460/mir-338-3p/MCM4 Regulatory Axis as Diagnostic and Prognostic Biomarker of Lung Adenocarcinoma Based on Comprehensive Bioinformatics Analysis and Experimental Validation. | Cancers (Basel) | 2022 | 36291859 | PubTator, text mining | PubMed |
| Rosmarinic Acid and Related Dietary Supplements: Potential Applications in the Prevention and Treatment of Cancer. | Biomolecules | 2022 | 36291619 | PubTator, text mining | PubMed |
| Exploiting the Molecular Basis of Oesophageal Cancer for Targeted Therapies and Biomarkers for Drug Response: Guiding Clinical Decision-Making. | Biomedicines | 2022 | 36289620 | PubTator, text mining | PubMed |
| Dopachrome tautomerase is a retinoblastoma-specific gene, and its proximal promoter is preferentially active in human retinoblastoma cells. | Mol Vis | 2022 | 36274817 | PubTator, text mining | PubMed |
| TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | Cell Rep | 2022 | 36261009 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4176/papers?page=17